COMMUNICATION
|
doi:10.20944/preprints202409.0274.v1
Subject:
Medicine And Pharmacology,
Epidemiology And Infectious Diseases
Keywords:
COVID-19; Paxlovid; Nirlmetralvir; IFNAR2; OAS1; OAS3; ACE2
Online: 3 September 2024 (23:25:33 CEST)